JOHANNESBURG, Feb 11 (Reuters) - The African Union's disease
control body is in discussions with Johnson & Johnson
for the supply of more COVID-19 vaccine doses, its director John
Nkengasong said on Thursday.
Nkengasong added that the body was not expecting a delay to
vaccination in Africa after a trial showed AstraZeneca's
vaccine offered minimal protection against mild to moderate
illness from the 501Y.V2 variant dominant in South Africa.
(Reporting by Alexander Winning, Olivia Kumwenda-Mtambo and
Emma Rumney; Editing by Alison Williams)